Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.220
Filter
1.
BMJ Case Rep ; 17(7)2024 Jul 10.
Article in English | MEDLINE | ID: mdl-38991567

ABSTRACT

We present a case of a primigravida in her 30s who had a caesarean delivery of dichorionic diamniotic twins at 33 weeks of gestation. Her postpartum course was complicated by a herpes simplex virus (HSV) infection of her nipple, found after her neonates were diagnosed with HSV encephalitis. She was evaluated at her 3-week postpartum visit and reported that her neonates were concurrently admitted to the neonatal intensive care unit with disseminated neonatal HSV-1. The patient and her partner were in a monogamous relationship with no known history of HSV. Physical examination demonstrated a vertical fissure on the face of her right nipple and a small cluster of vesicles on her left hand. PCR swabs of the lesions were positive for HSV-1 at both locations. The patient was started on oral valacyclovir 1000 mg two times per day, topical acyclovir ointment applied 4-6 times per day and mupirocin ointment applied 3 times per day to her breast with resolution of her breast lesions. She was able to continue expressing her breastmilk with the help of a pump and then resumed breastfeeding once her infection was cleared. Her infants recovered after prolonged parenteral antiviral therapy with age-appropriate development at follow-up.


Subject(s)
Acyclovir , Antiviral Agents , Encephalitis, Herpes Simplex , Herpes Simplex , Herpesvirus 1, Human , Nipples , Humans , Female , Antiviral Agents/therapeutic use , Antiviral Agents/administration & dosage , Infant, Newborn , Acyclovir/therapeutic use , Acyclovir/administration & dosage , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Herpesvirus 1, Human/isolation & purification , Encephalitis, Herpes Simplex/diagnosis , Encephalitis, Herpes Simplex/drug therapy , Valacyclovir/therapeutic use , Valacyclovir/administration & dosage , Pregnancy Complications, Infectious/diagnosis , Adult , Pregnancy , Infectious Disease Transmission, Vertical , Valine/analogs & derivatives , Valine/therapeutic use , Valine/administration & dosage , Breast Feeding
2.
BMJ Glob Health ; 9(7)2024 Jul 04.
Article in English | MEDLINE | ID: mdl-38964879

ABSTRACT

INTRODUCTION: Low-income and middle-income countries (LMICs) have a high burden of herpes simplex virus type 2 (HSV-2) infection, which has been strongly associated with HIV. In 2001, the WHO hosted a workshop to set research priorities for HSV-2 in LMICs. Periodic re-evaluation of research priorities is essential to ensure effective allocation of resources. This study describes the progress made between 2000 and 2020 in addressing the priorities identified in two of the five thematic areas that were the workshop's focus: HSV-2 epidemiology and diagnostics. The remaining areas are addressed in a companion paper. METHODS: A systematic search of MEDLINE, CINAHL, Global Health and Cochrane databases was carried out. Relevant primary and secondary research studies conducted in LMICs, written in English and published from 2000-2020 were included. Two independent researchers screened, identified papers and extracted preidentified variables from study texts. Data were organised into an Excel spreadsheet and analysed using IBM SPSS V.26. RESULTS: Overall, 4445 discrete papers were identified, of which 165 publications were eligible for inclusion. The highest general population HSV-2 prevalence was reported in South and West Africa. Prevalence was higher among women than men and increased with age. HSV-2 prevalence studies among key populations were few, and the majority were in East and South Asia. Cohort studies of HSV-2 incidence among younger populations (mean age=25 years) and HSV-2 infection prevalence in North Africa and the Middle East were few. The most researched topic in HSV-2 diagnostics addressed serological techniques and direct molecular biology. Studies of point-of-care testing were also few. CONCLUSION: HSV-2 research identified in LMICs has mainly addressed the epidemiology and diagnostics priorities identified by the 2001 WHO workshop. Unaddressed priorities include point-of-care testing, antiviral resistance and exploration of HSV-2 epidemiology in neglected geographical settings and population subgroups.


Subject(s)
Developing Countries , Herpes Genitalis , Herpesvirus 2, Human , Female , Humans , Male , Herpes Genitalis/epidemiology , Herpes Genitalis/diagnosis , Herpes Simplex/epidemiology , Herpes Simplex/diagnosis , Herpesvirus 2, Human/isolation & purification , Prevalence , World Health Organization
5.
Pediatrics ; 154(1)2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38910522

ABSTRACT

OBJECTIVES: To assess the management and outcomes of afebrile infants who received a pediatric dermatology consultation for pustules and/or vesicles. METHODS: Medical records were reviewed for all infants 60 days of age or younger who received a pediatric dermatology consult across 6 academic institutions between September 1, 2013 and August 31, 2019 to identify those infants with pustules and/or vesicles. RESULTS: Of the 879 consults, 183 afebrile infants presented with pustules and/or vesicles. No cerebrospinal fluid cultures or blood cultures were positive for bacteria. No concordant positive urine cultures were identified in infants with cutaneous infection. Nine infants were diagnosed with herpes simplex virus (HSV). Five preterm infants were diagnosed with angioinvasive fungal infections. CONCLUSIONS: No serious bacterial infections attributable to a skin source were identified, yet 53% of these infants received parenteral antibiotics. HSV was diagnosed in 7% of this cohort, 77.8% (7/9) of whom were term infants and 22.2% (2 of 9) of whom were preterm. Angioinvasive fungal infection was diagnosed in 3%, all of whom (100%, 5 of 5) were extremely preterm at <28 weeks gestational age. These findings suggest that in full-term afebrile infants ≤60 days, the likelihood of a life-threatening etiology of isolated pustules or vesicles is low once HSV infection is excluded. In preterm infants with pustules and/or vesicles, a high index of suspicion must be maintained, and broad infectious evaluation is recommended. HSV testing is recommended for all infants with vesicles, grouped pustules and/or punched-out erosions.


Subject(s)
Herpes Simplex , Humans , Infant, Newborn , Infant , Male , Female , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Retrospective Studies , Infant, Premature , Anti-Bacterial Agents/therapeutic use , Skin Diseases, Vesiculobullous/diagnosis , Dermatology
6.
Eur J Obstet Gynecol Reprod Biol ; 299: 193-198, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38885560

ABSTRACT

Fetal primary hydrothorax is a rare congenital anomaly with an estimated incidence of 1:10,000-15,000 pregnancies, with an unpredictable clinical course, ranging from spontaneous resolution to fetal death. A case of unilateral fetal pleural effusion was diagnosed at 35th week of gestation during a routine ultrasonographic fetal assessment in an uncomplicated pregnancy. A large echogenic collection of fluid was revealed in the right pleural cavity, together with atelectasis of the right lung, as well as displacement of heart and mediastinal structures to the left side of thorax. The patient was also diagnosed with polyhydramnios and there was a disproportion of heart ventricles volume. No other fetal structural abnormalities were detected and there were no symptoms of edema. Fetal biometrics was consistent with the gestational age. In echocardiography, fetal heart was structurally and functionally normal. Screening tests for congenital infections of the fetus were negative. Autoimmune fetal hydrops was excluded after laboratory tests. There was no parents' consent for the analysis of the karyotype. The patient presented clinical symptoms and was diagnosed with Herpes simplex virus infection and was treated with oral acyclovir. Serial fetal ultrasound exams showed gradual decrease in pleural fluid volume up to complete resolution in 38th week of pregnancy. Pregnancy was ended in the 38th week of gestation with a cesarean delivery of a healthy neonate. It is yet to be determined if there is a direct association between Herpes simplex virus infection in pregnancy and the risk of fetal pleural effusion. The incidence of fetal pleural effusion is low and the neonatal outcome difficult to be predicted. The optimum management of fetal pleural effusion should be subject to further studies to determine the best clinical practice.


Subject(s)
Herpes Simplex , Pleural Effusion , Pregnancy Complications, Infectious , Ultrasonography, Prenatal , Female , Humans , Pregnancy , Fetal Diseases/diagnostic imaging , Herpes Simplex/complications , Herpes Simplex/diagnosis , Herpes Simplex/diagnostic imaging , Hydrops Fetalis/diagnosis , Pleural Effusion/diagnostic imaging , Remission, Spontaneous
7.
Dermatol Online J ; 30(1)2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38762853

ABSTRACT

The knife-cut sign is a distinctive manifestation of herpes simplex virus (HSV) type 1 or HSV type 2 infection that has been described in at least 10 immunocompromised patients. It appears as an extremely painful linear erosion or fissure in an intertriginous area such as the body folds beneath the breast, or within the abdomen, or in the inguinal region. Also, concurrent HSV infection at other mucocutaneous sites, or viscera, or both have been observed. The patients had medical conditions (at least 9 patients) and/or immunosuppressive drug therapy (6 patients). The diagnosis of HSV infection was confirmed by viral culture (8 patients), biopsy (4 patients), direct fluorescence antibody testing (3 patients), immunohistochemistry staining (2 patients), polymerase chain reaction (2 patients), or Western blot serologic assay (1 patient). Knife-cut sign-associated HSV infection is potentially fatal; three patients died. However, clinical improvement or complete healing occurred in the patients who received oral valacyclovir (1 patient), or intravenous acyclovir (2 patients), or intravenous acyclovir followed by foscarnet (1 patient). In summary, HSV infection associated with a positive the knife-cut sign is a potentially fatal variant of HSV infection that occurs in the intertriginous areas of immunocompromised patients and usually requires intravenous antiviral therapy.


Subject(s)
Antiviral Agents , Herpes Simplex , Herpesvirus 1, Human , Immunocompromised Host , Humans , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Middle Aged , Female , Male , Antiviral Agents/therapeutic use , Aged , Herpesvirus 1, Human/isolation & purification , Adult , Valacyclovir/therapeutic use , Herpesvirus 2, Human/isolation & purification , Acyclovir/therapeutic use , Valine/analogs & derivatives , Valine/therapeutic use , Immunosuppressive Agents/therapeutic use , Immunosuppressive Agents/adverse effects , Foscarnet/therapeutic use
8.
Dermatol Online J ; 30(1)2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38762852

ABSTRACT

Herpetic geometric glossitis is a unique morphologic variant of HSV (herpes simplex virus) type 1 infection on the dorsum of the tongue that presents as an extremely painful linear central lingual fissure with a branched pattern. in the center of the tongue; there is a branched pattern of fissures that extend bilaterally from the central linear fissure. Herpetic geometric glossitis has been reported in 11 patients; 8 of these individuals were immunocompromised. Medical conditions and immunosuppressive medication treatment (7 patients) or only medical disorders (3 patients) or neither (1 patient) were present. HSV type 1 infection was diagnosed by viral culture in (7 patients), Tzanck preparation (2 patients) or clinically (2 patients). Mucocutaneous HSV infection at non-lingual locations--including the lips, labial mucosa, face and chest--were observed in 5 patients. All patients' symptoms and lesions responded to treatment with oral antiviral therapy: acyclovir (9 patients), famciclovir (1 patient) or valacyclovir (1 patient). The lingual pain and dorsal tongue fissures completely resolved completely within two to 14 days. In summary, herpetic geometric glossitis is a unique HSV type 1 infection, usually in immunocompromised patients, that occurs on the dorsal tongue and responds completely after treatment with orally administered antiviral therapy.


Subject(s)
Antiviral Agents , Glossitis , Herpes Simplex , Herpesvirus 1, Human , Immunocompromised Host , Humans , Glossitis/drug therapy , Glossitis/virology , Middle Aged , Female , Male , Antiviral Agents/therapeutic use , Herpes Simplex/drug therapy , Herpes Simplex/diagnosis , Herpesvirus 1, Human/isolation & purification , Adult , Aged , Acyclovir/therapeutic use , Valacyclovir/therapeutic use , Valine/analogs & derivatives , Valine/therapeutic use , Famciclovir/therapeutic use
9.
J Clin Microbiol ; 62(6): e0026324, 2024 Jun 12.
Article in English | MEDLINE | ID: mdl-38687020

ABSTRACT

Herpes simplex virus (HSV) infections are one of the most common and stigmatized infections of humankind, affecting more than 4 billion people around the world and more than 100 million Americans. Yet, most people do not know their infection status, and antibody testing is not recommended, partly due to poor test performance. Here, we compared the test performance of the Roche Elecsys HSV-1 IgG and HSV-2 IgG, DiaSorin LIAISON HSV-1/2 IgG, and Bio-Rad BioPlex 2200 HSV-1 and HSV-2 IgG assays with the gold-standard HSV western blot in 1,994 persons, including 1,017 persons with PCR or culture-confirmed HSV-1 and/or HSV-2 infection. Across all samples, the Bio-Rad and Roche assays had similar performance metrics with low sensitivity (<85%) but high specificity (>97%) for detecting HSV-1 IgG and both high sensitivity (>97%) and high specificity (>98%) for detecting HSV-2 IgG. The DiaSorin assay had a higher sensitivity (92.1%) but much lower specificity (88.7%) for detecting HSV-1 IgG and comparatively poor sensitivity (94.5%) and specificity (94.2%) for detecting HSV-2 IgG. The DiaSorin assay performed poorly at low-positive index values with 60.9% of DiaSorin HSV-1 results and 20.8% of DiaSorin HSV-2 results with positive index values <3.0 yielding false positive results. Based on an estimated HSV-2 seroprevalence of 12% in the United States, positive predictive values for HSV-2 IgG were 96.1% for Roche, 87.4% for Bio-Rad, and 69.0% for DiaSorin, meaning nearly one of every three positive DiaSorin HSV-2 IgG results would be falsely positive. Further development in HSV antibody diagnostics is needed to provide appropriate patient care.IMPORTANCESerological screening for HSV infections is currently not recommended in part due to the poor performance metrics of widely used commercial HSV-1 and HSV-2 IgG assays. Here, we compare three Food and Drug Administration (FDA)-cleared automated HSV-1 and HSV-2 IgG assays to the gold-standard western blot across nearly 2,000 samples. We find that not all commercially available HSV assays are created equal, with comparably low sensitivities for HSV-1 IgG across platforms and high false positivity rates for DiaSorin on HSV-2 IgG. This study is the first large-scale comparison of performance metrics for the Bio-Rad and Roche assays in over 10 years. Our study confirms that there remains room for improvement in HSV serological diagnostic testing-especially in regard to low sensitivities for HSV-1 IgG detection-and highlights that some previously less-studied assays may have better performance metrics than previously considered typical of commercially available HSV-2 IgG assays.


Subject(s)
Antibodies, Viral , Herpes Simplex , Herpesvirus 1, Human , Herpesvirus 2, Human , Immunoglobulin G , Sensitivity and Specificity , Humans , Immunoglobulin G/blood , Herpesvirus 1, Human/immunology , Herpesvirus 2, Human/immunology , Herpesvirus 2, Human/isolation & purification , Antibodies, Viral/blood , Herpes Simplex/diagnosis , Herpes Simplex/virology , Male , Female , Adult , Middle Aged , Adolescent , Young Adult , Aged , Automation, Laboratory , Child , Aged, 80 and over , Immunoassay/methods , Child, Preschool
11.
Digit J Ophthalmol ; 30(1): 1-4, 2024.
Article in English | MEDLINE | ID: mdl-38601900

ABSTRACT

Background: Laboratory confirmation is crucial for diagnosis and management of herpes simplex virus (HSV) keratitis. However, the sensitivity of polymerase chain reaction (PCR) in keratitis is low (25%) compared with that of mucocutaneous disease (75%). We developed an educational intervention aimed at improving the diagnostic yield of PCR. Methods: The medical records of keratitis cases seen at the emergency department of a London tertiary ophthalmic referral hospital over two distinct periods, before and after an educational program on swab technique, were reviewed retrospectively. Results: A total of 252 HSV cases were included. Increases in the laboratory-confirmed diagnosis of HSV-1 were observed, in both first presentations (11.1%-57.7%) and recurrent cases (20%-57.6%). The rate of positive HSV-1 PCR in eyes with an epithelial defect increased from 19% pre-intervention to 62% post intervention. Notably, 3% were positive for varicella zoster virus DNA, and there was a single case of Acanthamoeba keratitis. Conclusion: Our results suggest that, with proper swabbing technique, PCR may be more sensitive than previously reported.


Subject(s)
Herpes Simplex , Herpesvirus 1, Human , Keratitis, Herpetic , Humans , Pilot Projects , Retrospective Studies , DNA, Viral/analysis , Keratitis, Herpetic/diagnosis , Herpesvirus 1, Human/genetics , Polymerase Chain Reaction/methods , Herpes Simplex/diagnosis
12.
BMJ Case Rep ; 17(3)2024 Mar 08.
Article in English | MEDLINE | ID: mdl-38458763

ABSTRACT

We report a baby with neonatal herpes simplex virus (HSV) encephalitis concurrent with Rrhesus (Rh) incompatibility. He was delivered by a Ggravida 2 mother with a history of miscarriage in her previous pregnancy at a gestation age of 4 months. She had Bblood group 0 and Rrhesus negative. The baby was noticed to have jaundice on day one1 of life accompanied by generalised petechiae on the face and upper chest. A full blood picture revealed severe anaemia and severe thrombocytopaenia and HSV 1/2 IgM was positive. MRI of the brain showed multiple extensive haemorrhagic lesions on the frontal-temporal regions.


Subject(s)
Encephalitis, Herpes Simplex , Herpes Simplex , Pregnancy Complications, Infectious , Male , Infant, Newborn , Infant , Pregnancy , Female , Humans , Herpes Simplex/complications , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Encephalitis, Herpes Simplex/complications , Pregnancy Complications, Infectious/diagnosis , Simplexvirus
13.
J Hematop ; 17(2): 91-96, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38418769

ABSTRACT

Hemophagocytic lymphohistiocytosis is a severe hyperinflammatory syndrome that can be potentially life-threatening without appropriate treatment. Although viral infection is the most common trigger of hemophagocytic lymphohistiocytosis, cases of herpes simplex virus type 1-induced hemophagocytic lymphohistiocytosis are rare in adults. This study aims to provide a comprehensive overview of the clinical characteristics and treatment outcomes associated with HSV-1-induced HLH. We herein report an adult case of hemophagocytic lymphohistiocytosis caused by herpes simplex virus type 1, diagnosed on the basis of peripheral blood metagenomic next-generation sequencing results. The patient exhibited a favorable response to treatment, involving dexamethasone, intravenous immunoglobulin, and acyclovir. Notably, etoposide administration was deemed unnecessary, and there has been no recurrence of the disease within the year following treatment. Early and sensitive recognition, rapid and precise diagnosis, and timely and appropriate treatment facilitated the successful treatment of this case.


Subject(s)
Herpes Simplex , Herpesvirus 1, Human , Lymphohistiocytosis, Hemophagocytic , Humans , Lymphohistiocytosis, Hemophagocytic/diagnosis , Lymphohistiocytosis, Hemophagocytic/virology , Lymphohistiocytosis, Hemophagocytic/drug therapy , Herpesvirus 1, Human/isolation & purification , Herpesvirus 1, Human/genetics , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Herpes Simplex/virology , Herpes Simplex/complications , Male , Adult , Dexamethasone/therapeutic use , Dexamethasone/administration & dosage , Acyclovir/therapeutic use , Acyclovir/administration & dosage , Antiviral Agents/therapeutic use
15.
J Am Acad Dermatol ; 91(1): 180-183, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38417590
16.
BMC Infect Dis ; 24(1): 225, 2024 Feb 20.
Article in English | MEDLINE | ID: mdl-38378498

ABSTRACT

BACKGROUND: Fusobacterium nucleatum (F. nucleatum) belongs to the genus Fusobacterium, which is a gram-negative obligate anaerobic bacterium. Bacteremia associated with F. nucleatum is a serious complication, which is not common in clinic, especially when it is combined with other intracranial pathogenic microorganism infection. We reported for the first time a case of F. nucleatum bacteremia combined with intracranial Porphyromonas gingivalis (P. gingivalis) and herpes simplex virus type 1(HSV-1) infection. CASE PRESENTATION: A 60-year-old woman was admitted to our hospital with a headache for a week that worsened for 2 days. Combined with history, physical signs and examination, it was characterized as ischemic cerebrovascular disease (ICVD). F. nucleatum was detected in blood by matrix-assisted laser desorption/ionization time-offight mass spectrometry (MALDI-TOF-MS). Meanwhile, P. gingivalis and HSV-1 in cerebrospinal fluid (CSF) were identified by metagenome next generation sequencing (mNGS). After a quick diagnosis and a combination of antibiotics and antiviral treatment, the patient recovered and was discharged. CONCLUSION: To our knowledge, this is the first report of intracranial P. gingivalis and HSV-1 infection combined with F. nucleatum bacteremia.


Subject(s)
Bacteremia , Fusobacterium Infections , Herpes Simplex , Herpesvirus 1, Human , Female , Humans , Middle Aged , Porphyromonas gingivalis , Fusobacterium nucleatum , Herpesvirus 1, Human/genetics , Base Composition , Phylogeny , RNA, Ribosomal, 16S , Sequence Analysis, DNA , Herpes Simplex/complications , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Bacteremia/complications , Bacteremia/diagnosis , Bacteremia/drug therapy , Fusobacterium Infections/complications , Fusobacterium Infections/diagnosis , Fusobacterium Infections/drug therapy
17.
Rev. chil. infectol ; 41(1): 106-156, feb. 2024. ilus, tab, graf
Article in Spanish | LILACS | ID: biblio-1559660

ABSTRACT

Las infecciones perinatales son una causa de morbilidad, tanto fetal como neonatal, y que compromete la salud de la mujer embarazada, por lo que su diagnóstico, tratamiento, e intento de eliminación son una prioridad en América Latina y el Caribe. Este documento representa la segunda entrega realizada por expertos en la región dentro de la Sociedad Latinoamericana de Infectología Pediátrica (SLIPE), brindando una mirada actualizada en el manejo de las infecciones congénitas y entrega herramientas para detectar posibles momentos estratégicos de intervención y cambio en el manejo de las infecciones congénitas.


Perinatal infections are a major cause of morbidity and mortality in the fetus, neonate, and the health of the pregnant woman. Diagnosis, treatment, and the search for elimination of these diseases are a priority in Latin America and the Caribbean. This document represents the second delivery by a group of experts in the region inside the Latin-American Society of Pediatric Infectious Diseases (SLIPE), presenting a up-to-date look into the management of congenital infectious diseases and give a tool to detect possible strategic sceneries and a change in the management of congenital infections in our region.


Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/therapy , Arbovirus Infections/congenital , Arbovirus Infections/diagnosis , Arbovirus Infections/therapy , Toxoplasmosis/diagnosis , Toxoplasmosis/therapy , Toxoplasmosis, Congenital , Communicable Diseases , Cytomegalovirus Infections , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/therapy , Dengue , Zika Virus Infection , COVID-19 , Herpes Simplex/congenital , Herpes Simplex/diagnosis , Herpes Simplex/therapy
18.
Ocul Immunol Inflamm ; 32(3): 351-354, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38330153

ABSTRACT

PURPOSE: The objective of this study is to report a case of unilateral acute retinal necrosis (ARN) with contralateral eye presenting as non-necrotizing herpetic uveitis. CASE REPORTS: Case 1: A 48-year-old female presented at our clinic with blurred vision in the right eye for 7 days. She was diagnosed with ARN in the left eye 2 weeks ago. Ophthalmic examination revealed reduced visual acuity in the right eye (20/33) with the presence of optic disc swelling and macular exudation without peripheral necrotic lesions. With systemic antiviral therapy, optic disc swelling of the right eye vanished gradually, and the visual acuity improved to 20/20. Loss of retinal nerve fiber layer (RNFL) and decreased retinal thickness in the corresponding area occurred during follow-up. CONCLUSION: Non-necrotizing herpetic uveitis may occur in the contralateral eye of unilateral ARN under rare conditions. Structure abnormities, including loss of RNFL and focal decreased retinal thickness, are irretrievable.


Subject(s)
Herpes Simplex , Herpes Zoster Ophthalmicus , Retinal Necrosis Syndrome, Acute , Uveitis , Female , Humans , Middle Aged , Retinal Necrosis Syndrome, Acute/diagnosis , Retinal Necrosis Syndrome, Acute/drug therapy , Uveitis/complications , Uveitis/diagnosis , Uveitis/drug therapy , Herpes Simplex/complications , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy , Retina , Herpes Zoster Ophthalmicus/complications , Herpes Zoster Ophthalmicus/diagnosis , Herpes Zoster Ophthalmicus/drug therapy
20.
Eye (Lond) ; 38(1): 61-67, 2024 01.
Article in English | MEDLINE | ID: mdl-37419957

ABSTRACT

AIMS: To present current expert practice patterns and to formulate a consensus for the management of HSV and VZV AU by uveitis specialists worldwide. METHODS: A two-round online modified Delphi survey with masking of the study team was conducted. Responses were collected from 76 international uveitis experts from 21 countries. Current practices in the diagnosis and treatment of HSV and VZV AU were identified. A working group (The Infectious Uveitis Treatment Algorithm Network [TITAN]) developed data into consensus guidelines. Consensus is defined as a particular response towards a specific question meeting ≥75% of agreement or IQR ≤ 1 when a Likert scale is used. RESULTS: Unilaterality, increased intraocular pressure (IOP), decreased corneal sensation and diffuse or sectoral iris atrophy are quite specific for HSV or VZV AU from consensus opinion. Sectoral iris atrophy is characteristic of HSV AU. Treatment initiation is highly variable, but most experts preferred valacyclovir owing to simpler dosing. Topical corticosteroids and beta-blockers should be used if necessary. Resolution of inflammation and normalisation of IOP are clinical endpoints. CONCLUSIONS: Consensus was reached on several aspects of diagnosis, choice of initial treatment, and treatment endpoints for HSV and VZV AU. Treatment duration and management of recurrences varied between experts.


Subject(s)
Herpes Simplex , Herpes Zoster Ophthalmicus , Herpes Zoster , Uveitis, Anterior , Uveitis , Humans , Herpesvirus 3, Human , Simplexvirus , Herpes Zoster Ophthalmicus/diagnosis , Herpes Zoster Ophthalmicus/drug therapy , Uveitis, Anterior/diagnosis , Uveitis, Anterior/drug therapy , Atrophy , Herpes Simplex/diagnosis , Herpes Simplex/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...